Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 43, 2013 - Issue 3
194
Views
1
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours

, , , , , & show all
Pages 276-282 | Received 01 Feb 2012, Accepted 16 Jul 2012, Published online: 29 Aug 2012

References

  • Boeckmann AJ, Sheiner LB, Beal SL. (1994). NONMEM users guide. San Francisco: NONMEM Project Group.
  • Boos J, Krümpelmann S, Schulze-Westhoff P, Euting T, Berthold F, Jürgens H. (1995). Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation? J Clin Oncol 13:2954–2960.
  • Diaz MA, Vicent MG, Madero L. (1999). High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Bone Marrow Transplant 24:1157–1159.
  • D’Incalci M, Farina P, Sessa C, Mangioni C, Conter V, Masera G, Rocchetti M, Pisoni MB, Piazza E, Beer M, Cavalli F. (1982). Pharmacokinetics of VP16-213 given by different administration methods. Cancer Chemother Pharmacol 7:141–145.
  • Evans WE, Sinkule JA, Crom WR, Dow L, Look AT, Rivera G. (1982). Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer. Cancer Chemother Pharmacol 7:147–150.
  • Hale GA. (2005). Autologous hematopoietic stem cell transplantation for pediatric solid tumors. Expert Rev Anticancer Ther 5:835–846.
  • Hutson PR, Sinkule JA, Hayes FA, Evans WE. (1983). Pharmacokinetics of etoposide (VP-16) in children with refractory solid tumors. Drug Intell Clin Pharm 17:442.
  • Iacono LC, Turner PK, Stewart CF. (2004). Pharmacokinetics of anticancer drugs in children. In: Figg WD, McLeod HL (ed.). Handbook of anticancer pharmacokinetics and pharmacodynamics. Totowa, NJ:Humana Press; 395–419.
  • Jonsson EN, Karlsson MO. (1999). Xpose–an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58:51–64.
  • Kato Y, Nishimura S, Sakura N, Ueda K. (2003). Pharmacokinetics of etoposide with intravenous drug administration in children and adolescents. Pediatr Int 45:74–79.
  • Kletzel M, Hewlett B. (2005). Pediatric transplantation: results in solid tumors. Curr Hematol Rep 4:260–269.
  • Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein FG, Schulz A, Wawer A, Zintl F, Graf N. (2002). High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 30:893–898.
  • Lowis SP, Pearson AD, Newell DR, Cole M. (1993). Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation. Cancer Res 53:4881–4889.
  • Mahmood I. (2006). Prediction of drug clearance in children from adults: a comparison of several allometric methods. Br J Clin Pharmacol 61:545–557.
  • Manouilov KK, McGuire TR, Gordon BG, Gwilt PR. (1998). Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 707:342–346.
  • Nieto Y, Vaughan WP. (2004). Pharmacokinetics of high-dose chemotherapy. Bone Marrow Transplant 33:259–269.
  • Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC. (1998). Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors. J Clin Oncol 16:937–944.
  • Palle J, Frost BM, Britt-Marie F, Gustafsson G, Göran G, Hellebostad M, Marit H, Kanerva J, Jukka K, Liliemark E, Eva L, Schmiegelow K, Kjeld S, Lönnerholm G, Gudmar L; Nordic Society of Paediatric Haematology and Oncology. (2006). Etoposide pharmacokinetics in children treated for acute myeloid leukemia. Anticancer Drugs 17:1087–1094.
  • Porrata LF, Adjei AA. (2001). The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours. Br J Cancer 85:484–489.
  • Rodman JH, Murry DJ, Madden T, Santana VM. (1994). Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation. J Clin Oncol 12:2390–2397.
  • Sinkule JA, Hutson P, Hayes FA, Etcubanas E, Evans W. (1984). Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. Cancer Res 44:3109–3113.
  • Wolff SN, Hainsworth JD, Greco FA. (2008). High-dose etoposide: from phase I to a component of curative therapy. J Clin Oncol 26:5310–5312.
  • Würthwein G, Klingebiel T, Krümpelmann S, Metz M, Schwenker K, Kranz K, Lanvers C, Boos J. (2002). Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens. Anticancer Drugs 13:101–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.